These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 16760836

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Terbinafine-induced subacute cutaneous lupus erythematosus in two patients with systemic lupus erythematosus successfully treated with topical corticosteroids.
    Kalińska-Bienias A, Kowalewski C, Woźniak K.
    Postepy Dermatol Alergol; 2013 Aug; 30(4):261-4. PubMed ID: 24278085
    [Abstract] [Full Text] [Related]

  • 43. Oral terbinafine and erythema multiforme.
    Todd P, Halpern S, Munro DD.
    Clin Exp Dermatol; 1995 May; 20(3):247-8. PubMed ID: 7671425
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T, Tiihonen R, Soini M, Wangel M, Sipponen A, Jokinen JJ.
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [Abstract] [Full Text] [Related]

  • 49. [Oral terbinafine-induced plantar pustular psoriasis].
    Le Guyadec T, Saint-Blancard P, Bosonnet S, Le Vagueresse R, Lanternier G.
    Ann Dermatol Venereol; 2000 Mar; 127(3):279-81. PubMed ID: 10804301
    [Abstract] [Full Text] [Related]

  • 50. Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis.
    Hindosh N, Kotala R, Probasco L, Bal S.
    Cureus; 2022 Apr; 14(4):e23887. PubMed ID: 35530818
    [Abstract] [Full Text] [Related]

  • 51. [Limits of brief treatment of onychomycoses].
    Seebacher C.
    Hautarzt; 1998 Sep; 49(9):705-8. PubMed ID: 9794158
    [Abstract] [Full Text] [Related]

  • 52. Oral terbinafine-induced bullous pemphigoid.
    Aksakal BA, Ozsoy E, Arnavut O, Ali Gürer M.
    Ann Pharmacother; 2003 Nov; 37(11):1625-7. PubMed ID: 14565807
    [Abstract] [Full Text] [Related]

  • 53. Terbinafine-induced lupus erythematosus.
    Murphy M, Barnes L.
    Br J Dermatol; 1998 Apr; 138(4):708-9. PubMed ID: 9640387
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Interaction between terbinafine and warfarin.
    Gupta AK, Ross GS.
    Dermatology; 1998 Apr; 196(2):266-7. PubMed ID: 9568423
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C, Karokis D, Liossis SC.
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [Abstract] [Full Text] [Related]

  • 59. A Case Report of Widespread Majocchi's Granuloma in a Patient with Systemic Lupus Erythematosus.
    Zhou S, Yang Y, Liu K, Huang S, Hu Y, Zhou X.
    Mycopathologia; 2017 Jun; 182(5-6):577-581. PubMed ID: 28083794
    [Abstract] [Full Text] [Related]

  • 60. Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.
    Drake LA, Shear NH, Arlette JP, Cloutier R, Danby FW, Elewski BE, Garnis-Jones S, Giroux JM, Gratton D, Gulliver W, Hull P, Jones HE, Journet M, Krol AL, Leyden JJ, Maddin SC, Ross JB, Savin RC, Scher RK, Sibbald GR, Tawfik NH, Zaias N, Tolpin M, Evans S, Birnbaum JE.
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):740-5. PubMed ID: 9366820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.